Key result
Among 1,537 Indian patients with atrial fibrillation, rheumatic heart disease was the leading etiology (47.6%), and 1-year outcomes included 6.5% mortality, 8% hospitalization, and 1% stroke.
Why the study?
A national registry was needed to capture epidemiological data, clinical presentation, treatment practices, and 1-year outcomes of AF patients in India.
Cohort (n=1,537)
Yes
In India, patients with atrial fibrillation present at a younger age, predominantly due to rheumatic heart disease, and face significant 1-year mortality and morbidity.
Maps AF epidemiology and care gaps in India; leaves open optimal management strategies for this population.
AIM: A national atrial fibrillation (AF) registry was conducted under the aegis of the Indian Heart Rhythm Society (IHRS), to capture epidemiological data-type of AF, clinical presentation and comorbidities, current treatment practices, and 1-year follow-up outcomes. METHODS: A total of 1537 patients were enrolled from 24 sites in India in the IHRS-AF registry from July 2011 to August 2012. Their baseline characteristics and follow-up data were recorded in case report forms and subsequently analyzed. RESULTS: The average age of Indian AF patients was 54.7 years. There was a marginal female preponderance - 51.5% females and 48.5% males. At baseline, 20.4% had paroxysmal AF; 33% had persistent AF; 35.1% had permanent AF and 11% had first AF episode. At one-year follow-up, 45.6% patients had permanent AF. Rheumatic valvular heart disease (RHD) was present in 47.6% of patients. Hypertension, heart failure, coronary artery disease, and diabetes were seen in 31.4%, 18.7%, 16.2%, and 16.1%, respectively. Rate control was the strategy used in 75.2% patients, digoxin and beta-blockers being the most frequently prescribed rate-control drugs. Oral anticoagulation (OAC) drugs were used in 70% of patients. The annual mortality was 6.5%, hospitalization 8%, and incidence of stroke 1%. CONCLUSIONS: In India, AF patients are younger and RHD is still the most frequent etiology. Almost two-third of the patients have persistent/permanent AF. At one-year follow-up, there is a significant mortality and morbidity in AF patients in India.
No takes yet. Share an insight, caveat, or question.
Vora et al. (2016) conducted a cohort in Atrial fibrillation (n=1,537). Atrial fibrillation was evaluated on Annual mortality. Among 1,537 Indian patients with atrial fibrillation, rheumatic heart disease was the leading etiology (47.6%), and 1-year outcomes included 6.5% mortality, 8% hospitalization, and 1% stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: